Found: 199
Select item for more details and to access through your institution.
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 1, p. 53, doi. 10.1007/s00428-022-03480-8
- By:
- Publication type:
- Article
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01169-6
- By:
- Publication type:
- Article
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01052-4
- By:
- Publication type:
- Article
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00968-7
- By:
- Publication type:
- Article
The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00960-1
- By:
- Publication type:
- Article
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0527-7
- By:
- Publication type:
- Article
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐19.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 6, p. e270, doi. 10.1111/ijlh.13310
- By:
- Publication type:
- Article
Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports.
- Published in:
- Cancer Reports, 2024, v. 7, n. 10, p. 1, doi. 10.1002/cnr2.2163
- By:
- Publication type:
- Article
Detection of contaminating tumor cells by RT-PCR in breast cancer patients.
- Published in:
- Bone Marrow Transplantation, 1999, v. 24, n. 2, p. 228, doi. 10.1038/sj.bmt.1701880
- By:
- Publication type:
- Article
Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 3, p. 285, doi. 10.1038/sj.bmt.1701326
- By:
- Publication type:
- Article
Hypermethylation of CXCR4 Promoter in CD34<sup>+</sup> Cells from Patients with Primary Myelofibrosis.
- Published in:
- Stem Cells, 2008, v. 26, n. 8, p. 1920, doi. 10.1634/stemcells.2008-0377
- By:
- Publication type:
- Article
Thrombopoietin Inhibits Murine Mast Cell Differentiation.
- Published in:
- Stem Cells, 2008, v. 26, n. 4, p. 912, doi. 10.1634/stemcells.2007-0777
- By:
- Publication type:
- Article
Molecular Profiling of CD34<sup>+</sup> Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1).
- Published in:
- Stem Cells, 2007, v. 25, n. 1, p. 165, doi. 10.1634/stemcells.2006-0351
- By:
- Publication type:
- Article
ABO blood group type and risk of venous thrombosis in essential thrombocythemia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 3, p. 699, doi. 10.1111/bjh.18906
- By:
- Publication type:
- Article
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 317, doi. 10.1111/bjh.18207
- By:
- Publication type:
- Article
Pregnancy in patients with myelofibrosis: Mayo–Florence series of 24 pregnancies in 16 women.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 133, doi. 10.1111/bjh.17626
- By:
- Publication type:
- Article
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 845, doi. 10.1111/bjh.17405
- By:
- Publication type:
- Article
Ventricular tachyarrhythmias and sudden cardiac death in light‐chain amyloidosis: a clash of cardio‐toxicities?
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. e27, doi. 10.1111/bjh.17399
- By:
- Publication type:
- Article
Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 291, doi. 10.1111/bjh.16380
- By:
- Publication type:
- Article
Comments on pre‐fibrotic myelofibrosis and how should it be managed.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 358, doi. 10.1111/bjh.15840
- By:
- Publication type:
- Article
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 76, doi. 10.1111/bjh.14382
- By:
- Publication type:
- Article
Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 938, doi. 10.1111/bjh.13644
- By:
- Publication type:
- Article
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 541, doi. 10.1111/bjh.13080
- By:
- Publication type:
- Article
The ERCC2 Gln/ Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 424, doi. 10.1111/bjh.12376
- By:
- Publication type:
- Article
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 229, doi. 10.1111/bjh.12375
- By:
- Publication type:
- Article
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 688, doi. 10.1111/bjh.12332
- By:
- Publication type:
- Article
Role of Thrombopoietin in Mast Cell Differentiation.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1106, p. 152, doi. 10.1196/annals.1392.024
- By:
- Publication type:
- Article
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1550, doi. 10.1002/ajh.27400
- By:
- Publication type:
- Article
Risk models in myelofibrosis—the past, present, and future.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 519, doi. 10.1002/ajh.27270
- By:
- Publication type:
- Article
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation‐enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. 68, doi. 10.1002/ajh.27136
- By:
- Publication type:
- Article
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1829, doi. 10.1002/ajh.27079
- By:
- Publication type:
- Article
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 12, p. 1959, doi. 10.1002/ajh.27026
- By:
- Publication type:
- Article
JAK2 inhibitor treatment of anemia in myelofibrosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 7, p. 995, doi. 10.1002/ajh.26934
- By:
- Publication type:
- Article
The international consensus classification of myeloid neoplasms and acute leukemias: Myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 544, doi. 10.1002/ajh.26821
- By:
- Publication type:
- Article
Diagnostic and therapeutic challenges in mast cell sarcoma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 529, doi. 10.1002/ajh.26804
- By:
- Publication type:
- Article
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 166, doi. 10.1002/ajh.26751
- By:
- Publication type:
- Article
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. E347, doi. 10.1002/ajh.26648
- By:
- Publication type:
- Article
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 846, doi. 10.1002/ajh.26548
- By:
- Publication type:
- Article
Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E35, doi. 10.1002/ajh.26423
- By:
- Publication type:
- Article
Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1580, doi. 10.1002/ajh.26336
- By:
- Publication type:
- Article
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1472, doi. 10.1002/ajh.26332
- By:
- Publication type:
- Article
Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E408, doi. 10.1002/ajh.26305
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Lenalidomide: A double‐edged sword for concomitant multiple myeloma and post‐essential thrombocythemia myelofibrosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 749, doi. 10.1002/ajh.26153
- By:
- Publication type:
- Article
Extreme thrombocytosis in low‐risk essential thrombocythemia: Retrospective review of vascular events and treatment strategies.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. E182, doi. 10.1002/ajh.26137
- By:
- Publication type:
- Article
Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140445
- By:
- Publication type:
- Article
mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054826
- By:
- Publication type:
- Article
High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015277
- By:
- Publication type:
- Article
Myeloid sarcoma: more and less than a distinct entity.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 1973, doi. 10.1007/s00277-023-05288-1
- By:
- Publication type:
- Article